Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Cadence Pharmaceuticals received early financing of $86.6M on 2009-02-23.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $86.6M | 02/2009 |
| Investors | Security type |
|---|---|
| Bay City Capital | Post Ipo Equity |
| New Enterprise Associates (NEA) | Post Ipo Equity |
| Versant Ventures | Post Ipo Equity |
| Venrock | Post Ipo Equity |
| Frazier Healthcare Partners | Post Ipo Equity |
| T. Rowe Price | Post Ipo Equity |
| Domain Associates | Post Ipo Equity |
Cadence Pharmaceuticals's top competitor, Catalyst Pharmaceuticals, earned an annual revenue of $491.7M.
Cadence Pharmaceuticals's smallest competitor is William Stilley with revenue of $200.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Santarus | - | $218.0M | 290 | - |
| Arbor Pharmaceuticals | - | $175.0M | 157 | - |
| Eagle Pharmaceuticals | - | $316.6M | 96 | - |
| Eton Pharmaceuticals | - | $959,000 | 10 | - |
| Anthera Pharmaceuticals | - | $1.0M | 21 | - |
| Tapestry Pharmaceuticals, Inc. | - | $6.1M | 38 | - |
| Anacor Pharmaceutical | - | $82.4M | 100 | - |
| Tonix Pharmaceuticals | - | $12.7M | 26 | - |
| William Stilley | - | $200,000 | 2 | - |
| Dova Pharmaceuticals | - | $10.4M | 115 | - |
Zippia gives an in-depth look into the details of Cadence Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cadence Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Cadence Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cadence Pharmaceuticals. The data presented on this page does not represent the view of Cadence Pharmaceuticals and its employees or that of Zippia.
Cadence Pharmaceuticals may also be known as or be related to CADENCE PHARMACEUTICALS INC and Cadence Pharmaceuticals.